Published 20 hours ago • loading... • Updated 20 hours ago

Biotech Growth Trust Portfolio Manager On Valuations, M&A And Sector Recovery

Biotech Growth Trust Co-Portfolio Manager Josh Golomb discusses the long-term investment opportunity in biotechnology, BIOG’s recent performance, recovering valuations, pharmaceutical M&A activity and developments in cancer treatments.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

DirectorsTalk Interviews

Biotech Growth Trust Portfolio Manager On Valuations, M&A And Sector Recovery

20 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated18 hours agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

DirectorsTalk Interviews broke the news 20 hours ago on Wednesday, September 30, 2026.

Sources are mostly out of (0)

Biotech Growth Trust Portfolio Manager On Valuations, M&A And Sector Recovery

1 Articles

1 Articles

Biotech Growth Trust Portfolio Manager On Valuations, M&A And Sector Recovery

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Halper Sadeh LLC Is Investigating Whether LFCR and SSTI Are Obtaining Fair Deals for Their Shareholders

AMD to Buy Fei-Fei Li's World Labs for $8.2 Billion

SNU Business Club Alumni Caught in Alleged Insider Trading Scheme

Unicredit to Move Against Commerzbank as Early as 2027

Regulating AI 'not the right place to start' says Bailey

PR Newswire hosts AI search visibility event in London

Similar News Topics

Similar News Topics

More stories like this

Halper Sadeh LLC Is Investigating Whether LFCR and SSTI Are Obtaining Fair Deals for Their Shareholders

AMD to Buy Fei-Fei Li's World Labs for $8.2 Billion

SNU Business Club Alumni Caught in Alleged Insider Trading Scheme

Unicredit to Move Against Commerzbank as Early as 2027

Regulating AI 'not the right place to start' says Bailey

PR Newswire hosts AI search visibility event in London

Biotech Growth Trust Portfolio Manager On Valuations, M&A And Sector Recovery

1 Articles

1 Articles

Biotech Growth Trust Portfolio Manager On Valuations, M&A And Sector Recovery

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Halper Sadeh LLC Is Investigating Whether LFCR and SSTI Are Obtaining Fair Deals for Their Shareholders

AMD to Buy Fei-Fei Li's World Labs for $8.2 Billion

SNU Business Club Alumni Caught in Alleged Insider Trading Scheme

Unicredit to Move Against Commerzbank as Early as 2027

Regulating AI 'not the right place to start' says Bailey

PR Newswire hosts AI search visibility event in London

Similar News Topics

Similar News Topics

More stories like this

Halper Sadeh LLC Is Investigating Whether LFCR and SSTI Are Obtaining Fair Deals for Their Shareholders

AMD to Buy Fei-Fei Li's World Labs for $8.2 Billion

SNU Business Club Alumni Caught in Alleged Insider Trading Scheme

Unicredit to Move Against Commerzbank as Early as 2027

Regulating AI 'not the right place to start' says Bailey

PR Newswire hosts AI search visibility event in London

Bias Distribution

Factuality